Northwest Biotherapeutics Inc.

Northwest Biotherapeutics Inc.

World Rank (Jan-05-2024)
11,833
World Rank (Jul-30-2023)
11,833
Market Cap (Jul-30-2023)
0.578 Billion USD
World Rank (Jan-07-2022)
11,641
Market Cap (Jan-07-2022)
0.668 Billion USD
Headquarters Country
USA
Employee Count
20
Employee Count as of Date
As on 2021
Headquarters City/State
Maryland
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
2 Million USD
Annual Operating Income in USD
-67 Million USD
Annual Net Income in USD
-105 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
31 Million USD
Total Liabilities in USD
159 Million USD
Total Equity in USD
-128 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Biotechnology
Company Website
NORTHWEST BIOTHERAPEUTICS, INC.
Company Profile
Northwest Biotherapeutics, Inc is a Clinical Stage Biotechnology company focused on the development of personalized cancer vaccines designed to treat a broad range of solid tumor cancers. The company annual revenue is 1.29 million USD and 17 employees as on 2020. The headquarters is in USA.

Share